CTL Trusteeship Limited acting as Common Security Trustee for the benefit of the debenture trustee(s) of the Debentures and the respective Debenture holders
Ajanta Pharma Limited · NSE
+26,21,067 sh
Nippon India Small Cap Fund
0.8% of their portfolio
₹606.29 Cr
16,74,471 sh
Nippon India Pharma Fund
3.6% of their portfolio
₹330.91 Cr
9,13,918 sh
HDFC Large and Mid Cap Fund
1.1% of their portfolio
₹323.17 Cr
8,97,224 sh
Nippon India Multi Cap Fund
0.5% of their portfolio
₹268.86 Cr
7,42,553 sh
Aditya Birla Sun Life Midcap Fund
2.4% of their portfolio
₹162.23 Cr
4,73,984 sh
SBI Flexicap Fund
67.0% of their portfolio
₹154.88 Cr
4,30,000 sh
Aditya Birla Sun Life Flexi Cap Fund
0.5% of their portfolio
₹133.76 Cr
3,90,807 sh
Aditya Birla Sun Life Large Cap Fund
0.5% of their portfolio
₹133.76 Cr
3,90,807 sh
HDFC Multi Cap Fund
61.0% of their portfolio
₹126.07 Cr
3,50,000 sh
Aditya Birla Sun Life Large & Mid Cap Fund
2.1% of their portfolio
₹120.41 Cr
3,51,809 sh
SBI Healthcare Opportunities Fund
1.9% of their portfolio
₹107.83 Cr
2,99,382 sh
Aditya Birla Sun Life Balanced Advantage Fund
1.1% of their portfolio
₹105.30 Cr
3,07,661 sh
FIIs trimmed their stake −0.6pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
CTL Trusteeship Limited acting as Common Security Trustee for the benefit of the debenture trustee(s) of the Debentures and the respective Debenture holders
Ajanta Pharma Limited · NSE
+26,21,067 sh
Groww Mutual Fund (scheme IB18)
Ajanta Pharma Limited · NSE
806 sh · ₹29.18 L
Nippon India Nifty Pharma ETF
Ajanta Pharma Limited · NSE
80,268 sh · ₹29.06 Cr
Groww Mutual Fund (scheme IB54)
Ajanta Pharma Limited · NSE
167 sh · ₹6.05 L
Nippon India Multi Cap Fund
Ajanta Pharma Limited · NSE
7,42,553 sh · ₹268.86 Cr
ICICI Prudential Nifty Pharma Index Fund
Ajanta Pharma Limited · NSE
7,537 sh · ₹2.73 Cr
ICICI Prudential Nifty 500 Index Fund
Ajanta Pharma Limited · NSE
242 sh · ₹8.76 L
Nippon India Nifty Midcap 150 Index Fund
Ajanta Pharma Limited · NSE
30,195 sh · ₹10.93 Cr
Nippon India Small Cap Fund
Ajanta Pharma Limited · NSE
16,74,471 sh · ₹606.29 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
30 announcements on record for this company.
SBI Nifty Midcap 150 Momentum 50 ETF
64.0% of their portfolio
₹84.28 L
2,340 sh
Promoter holding by quarter: Jun 2025 66.3%, Sep 2025 66.3%, Dec 2025 66.3%, Mar 2026 66.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.3pp
FII holding by quarter: Jun 2025 8.9%, Sep 2025 8.5%, Dec 2025 8.0%, Mar 2026 8.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.2pp
DII holding by quarter: Jun 2025 17.5%, Sep 2025 17.9%, Dec 2025 18.6%, Mar 2026 18.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 14.7%, Sep 2025 14.7%, Dec 2025 15.5%, Mar 2026 15.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India Nifty 500 Equal Weight Index Fund
Ajanta Pharma Limited · NSE
2,598 sh · ₹94.07 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 66.3%, Sep 2025 66.3%, Dec 2025 66.3%, Mar 2026 66.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.3pp
FII holding by quarter: Jun 2025 8.9%, Sep 2025 8.5%, Dec 2025 8.0%, Mar 2026 8.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.2pp
DII holding by quarter: Jun 2025 17.5%, Sep 2025 17.9%, Dec 2025 18.6%, Mar 2026 18.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 14.7%, Sep 2025 14.7%, Dec 2025 15.5%, Mar 2026 15.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
30 announcements on record for this company.